Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glykos M 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Elkos Healthcare Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glykos M 80mg/500mg Tablet SR

DiabetaComb 80mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb 80mg/500mg ER Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication, even with controlled blood sugar, as discontinuation without consulting your doctor can lead to elevated blood glucose and potentially serious complications, including kidney impairment, vision loss, neuropathy, and limb amputation. Remember, it's crucial to combine this medication with a healthy diet, regular physical activity, and weight management as recommended by your healthcare provider for comprehensive diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation, and vomiting. Learn to recognize and treat hypoglycemia; maintain regular mealtimes and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your physician of any history of heart problems before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glykos M 80mg/500mg Tablet SR

Diabetes mellitus, type 2

Major Benefits of Glykos M 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glykos M 80mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glykos M 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glykos M 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Glykos M 80mg/500mg Sustained-Release Tablets should be taken with meals.

How Glykos M 80mg/500mg Tablet SR works:

Glykos M SR tablets (80mg/500mg) contain gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glykos M 80mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glykos M 80mg/500mg tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glykos M 80mg/500mg tablets are likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glykos M 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glykos M 80mg/500mg SR tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glykos M 80mg/500mg Tablet SR cautiously. Dosage modification of Glykos M 80mg/500mg Tablet SR might be necessary. Physician consultation is advised. A reduced initial dose of Glykos M 80mg/500mg Tablet SR is typically prescribed for those with mild to moderate liver disease; it's not recommended for patients exhibiting severe hepatic dysfunction.

What if you forget to take Glykos M 80mg/500mg Tablet SR :

Should you forget a Glykos M 80mg/500mg SR Tablet dose, administer it promptly. However, near the time for your next scheduled dose, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Glykos M 80mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glykos M 80mg/500mg Tablet SR

Glykos M 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glykos M is not suitable for type 1 diabetes.
Glykos M 80mg/500mg Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glykos M 80mg/500mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glykos M 80mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Glykos M and seek immediate medical attention.
Prolonged Glykos M 80mg/500mg Tablet SR use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended at least annually, according to some researchers.
Glykos M 80mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glykos M 80mg/500mg Tablet SR and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glykos M 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glykos M is not suitable for type 1 diabetes.
Glykos M 80mg/500mg SR Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glykos M 80mg/500mg SR tablets can cause low blood sugar (hypoglycemia), with symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is essential. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glykos M 80mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who don't consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glykos M 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged Glykos M 80mg/500mg Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glykos M 80mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glykos M 80mg/500mg SR tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glykos M 80mg/500mg Table...
57
MRP 69
17% off